CLINICAL TRIAL SUMMARY

MDACC Study No:2009-0362 (clinicaltrials.gov NCT No: NCT01098955)
Title:Smoking Cessation Treatment for Head & Neck Cancer Patients: Acceptance and Commitment Therapy
Principal Investigator:Jan Blalock
Treatment Agent:Smoking cessation counseling; Varenicline
Study Status:Closed
Study Description:This is Part 1 of a 2-part research study. The goal of this part of the study
is to plan and test an investigational type of counseling called Acceptance and
Commitment Therapy, for use in patients who have or had head and neck cancer,
lung cancer, breast cancer, gastrointestinal cancer, or genitourinary cancer.

This part of the study is also designed to train the study counselors how to
perform Acceptance and Commitment Therapy.

In this part of the study, participants will either receive Acceptance and
Commitment Therapy or the standard type of counseling, called Motivational and
Behavioral Counseling.

Hide details for General InformationGeneral Information

Disease Group:Breast; Gastrointestinal; Genitourinary; Head And Neck; Lung
Phase of Study:N/A
Treatment Agents:Smoking cessation counseling
Varenicline
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:Not applicable
Supported By:National Cancer Institute
Return Visit:7
Home Care:none


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Jan Blalock
Dept:Behavioral Science
For Clinical Trial Enrollment:713-745-1728
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults